[theold]

The action centers around three patents that CureVac claims BioNTech violated in its rapid creation of its megablockbuster vaccine. A fourth patent, which expired last month, relates the manufacture and sale of the vaccine. The other three patents won’t expire until the 2030s.

https://www.fiercepharma.com/pharma/cure...de-analyst